PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Health Data Science, Institute of Population Health, University of Liverpool, Liverpool, UK martaf@liverpool.ac.uk.\', \'Department of Health Data Science, Institute of Population Health, University of Liverpool, Liverpool, UK.\', \'Department of Health and Social Care, London, UK.\', \'William Harvey Research Institute, Queen Mary University of London, London, UK.\', \'Leeds Institute of Medical Research, University of Leeds, Leeds, UK.\', \'NIHR Health Protection Research Unit in Emerging and Zoonotic Infections and Institute of Translational Medicine, Faculty of Health and Life Sciences, University of Liverpool, Liverpool, UK.\', \'Respiratory Medicine, Alder Hey Children\'s Hospital, Liverpool, UK.\', \'Institute of Population Health Sciences, University of Liverpool, Liverpool, UK.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1136/bmj.n1637
?:doi
?:hasPublicationType
?:journal
  • BMJ (Clinical research ed.)
is ?:pmid of
?:pmid
?:pmid
  • 34230058
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Performance of the Innova SARS-CoV-2 antigen rapid lateral flow test in the Liverpool asymptomatic testing pilot: population based cohort study.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all